Adam E. Fine
InvestorGeneral Partner & CEO at Windham Capital Partners
New York, New York, United States
Find your path to Adam
180 people in our graph share verified history with Adam — schools, employers, funds. One of them is your warm intro.
Aydin SenkutunlockedAdam: together at Boston University (1991–1992)
×3Adam: together at Boston University
×3Adam: together at Neuspera Medical, Inc.
Adam: together at ChromaCode
About
Co-founder, General Partner and CEO of Windham Capital Partners, currently a board director at RxWare, Neuspera, Andros and Valera. Previously VP & GM at healthcare enterprise software company I-many, and earlier worked at Johnson & Johnson companies Cordis & Biosense and at Coopers & Lybrand.
Contact· self-published, not guessed
Invests in
BiotechDeep TechHardwareHealthtechSaaS
Experience
- Windham Capital PartnersFounder & Managing Partnercurrent2006 — present
- ChromaCode, Inc.Board Observercurrent2019 — present
- Upward Health (formerly BehaveCare)Board Observercurrent2017 — present
- androsBoard Membercurrent2017 — presentGreater New York City Area
- NeuSpera Medical Inc.Board Membercurrent2017 — presentSan Jose, California
Skills & more
Entrepreneurship21Strategy Development2
Languages Hebrew
From Adam's professional profile.
Colleagues at Windham Capital Partners
Alistair Erskine
Operating Partner at Windham Capital Partners
Allan Bufferd
Advisor at Windham Capital Partners
Bill Crouse
Advisor at Windham Capital Partners
David Kereiakes
Managing Partner at Windham Capital Partners
Deneen Vojta
Senior Advisor at Windham Capital Partners
Jason Helgerson
Operating Partner at Windham Capital Partners
Jeffrey Sachs
Advisor at Windham Capital Partners
Joe Proto
Co-Founder at Windham Capital Partners
Frequently asked questions
- Who is Adam E. Fine?
- Co-founder, General Partner and CEO of Windham Capital Partners, currently a board director at RxWare, Neuspera, Andros and Valera. Previously VP & GM at healthcare enterprise software company I-many, and earlier worked at Johnson & Johnson companies Cordis & Biosense and at Coopers & Lybrand.
- Where does Adam E. Fine work?
- Adam E. Fine is General Partner & CEO at Windham Capital Partners.
- What does Adam E. Fine invest in?
- Adam E. Fine invests in Biotech, Deep Tech, Hardware, Healthtech, SaaS.
- Where did Adam E. Fine go to school?
- Adam E. Fine studied at New York University (MBA, Finance); Boston University (BA, International Relations).
Same school
Also attended New York University721
Jonathan RossFounder of Groq; inventor of Google's TPU — now at NvidiaGabriella GiglioHR & Executive Talent at General CatalystAndrea EchstenkamperVP of Marketing at HeavybitRami BranitzkyPartner at Sapphire VenturesZach WhiteInvestment Team at 8VCAnkita TiwariPrograms Manager at StartX
+ 715 more
Shared employers
Also worked at ChromaCode, Inc.8
Marc AverittCo-Founder, Managing Director at Okapi Venture CapitalKabeer AzizCo-Founder and Partner at Adjuvant CapitalJenny YipManaging Partner at Adjuvant CapitalAditya RajagopalVenture Partner at +ND CapitalPaul FlookExecutive Officer, Director at ChromaCodeRyan DittamoreCEO at Cordance Medical
+ 2 more
Also worked at andros4
Also worked at NeuSpera Medical Inc.10
Mudit K. JainInvestor at Treo Ventures, LlcMudit JainFounding General Partner at Treo Ventures, LlcTracy PappasInvestor at Treo Ventures, LlcShaleen DevgunInvestor at TitletownTechLori HuManaging Director at Vertex Ventures HCJuan-Pablo MasPartner at Action Potential Venture Capital Ltd.
+ 4 more